When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Cytokine delivery systems - Wikipedia

   en.wikipedia.org/wiki/Cytokine_delivery_systems

   [2] [3] Cytokines hinder tumor cell development mostly through antiproliferative or proapoptotic pathways but can also interrupt development indirectly by eliciting immune cells to have cytotoxic effects against tumor cells. [2] Even though there are FDA-approved cytokine therapies, there are two main challenges associated with cytokine delivery.

3. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include GLP-1 agonists or SGLT2 inhibitors as a first-line pharmacological therapy for type 2 diabetes in patients who have or are at high risk for atherosclerotic cardiovascular disease or heart failure. They are also a first-line treatment for people with both ...

4. Is Ozempic the New Anti-Inflammatory Wonder Drug? - AOL

   www.aol.com/ozempic-anti-inflammatory-wonder...

   Some GLP-1s are now FDA approved for chronic weight management, including Wegovy (semaglutide) and Saxenda (liraglutide), while others like Ozempic (semaglutide) are approved for type 2 diabetes ...

5. Dulaglutide - Wikipedia

   en.wikipedia.org/wiki/Dulaglutide

   Dulaglutide, sold under the brand name Trulicity among others, [8] is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. [9] [10] It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.

6. FDA approves 1st drug to delay the onset of Type 1 diabetes - AOL

   www.aol.com/fda-approves-1st-drug-delay...

   The drug, called Tzield, is the first-ever FDA approved treatment intended to delay the onset of type 1 diabetes in adults and children ages 8 and up.

7. FDA Approves First-of-Its-Kind Drug to Delay Type 1 Diabetes

   www.aol.com/news/fda-approves-first-kind-drug...

   With type 1 diabetes, the body attacks itself. A person’s own immune system destroys the pancreas over time, leaving the critical organ unable to produce insulin and regulate blood sugar. Almost ...